Dr Lissak New York City, NY - 10065

Dr Lissak is categorized under Physical Medicine, Physician/Surgeon in New York City, NY and active since 2008.

Dr Lissak was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Matthew Lissak at the company’s single location by writing to 105 East 63rd St Apartment 2b, New York City, New York NY 10065 or by phoning (212) 838-0707. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dr Lissak
Contact Person: Matthew Lissak
Address: 105 East 63rd St Apartment 2b, New York City, New York 10065
Phone Number: (212) 838-0707
Website Address: drlissak.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physical Medicine, Physician/Surgeon
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Dr Lissak was started in 2008 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Matthew Lissak for inquiries that concern Dr Lissak by calling the company number (212) 838-0707, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Lissak can be found at the coordinates 40.765338,-73.967424 as well as the street address 105 East 63rd St Apartment 2b in New York City, New York 10065.

For its online presence, you may visit Dr Lissak’s website at drlissak.com and engage with its social media outlets through on Twitter and on Facebook.